Overview
Luis Llorente practices in Mexico City, Mexico. Mr. Llorente is highly rated in 6 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Sjogren Syndrome, Dry Mouth, Systemic Lupus Erythematosus (SLE), and Orchiectomy.
His clinical research consists of co-authoring 80 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ArthritisMr. Llorente isAdvanced. Learn about Arthritis.
- Dry Eye SyndromeMr. Llorente isAdvanced. Learn about Dry Eye Syndrome.
- Dry MouthMr. Llorente isAdvanced. Learn about Dry Mouth.
- Rheumatoid Arthritis (RA)Mr. Llorente isAdvanced. Learn about Rheumatoid Arthritis (RA).
- Sjogren SyndromeMr. Llorente isAdvanced. Learn about Sjogren Syndrome.
- Systemic Lupus Erythematosus (SLE)Mr. Llorente isAdvanced. Learn about Systemic Lupus Erythematosus (SLE).
- Experienced
- COVID-19Mr. Llorente isExperienced. Learn about COVID-19.
- EncephalitisMr. Llorente isExperienced. Learn about Encephalitis.
- Felty SyndromeMr. Llorente isExperienced. Learn about Felty Syndrome.
- Hashimoto ThyroiditisMr. Llorente isExperienced. Learn about Hashimoto Thyroiditis.
- IgG4-Related DiseaseMr. Llorente isExperienced. Learn about IgG4-Related Disease.
- Long Haul COVIDMr. Llorente isExperienced. Learn about Long Haul COVID.